Pfizer changes lives through digital transformation

Successes to date

While its digital transformation journey continues, PGS has documented major improvements to-date in areas like cycle time, manufacturing throughput and yield, and right-first-time quality. At just one manufacturing site, the digital transformation program has been credited with enabling the manufacture of 3 million additional doses of one product above what was planned for in 2019.

Something that’s helped drive the success of the program has been a willingness to explore new ideas and possibilities.

“Every time someone comes to me with a wild idea, it’s typically a, ‘Yes, go try that,’” Tomasco said. “And oftentimes they don’t understand why we didn’t have a committee to try to decide that.”

And while the team moved quickly in instances like deploying remote-collaboration tools, it also proved that “digital” doesn’t always need to mean “fast.”

“You’ve got to methodically plan this out and think, in three years, how am I going to benefit from this?” Tomasco said. “And that’s where we’re at now. We’ve been plotting out those foundational layers. And the ability and the rate and pace of what we can do now is now going up exponentially, because we’ve taken the time to build that foundation.”

Learn more about our Life Science Manufacturing Solutions.